Audit 404890

FY End
2025-09-30
Total Expended
$230.34M
Findings
0
Programs
46
Year: 2025 Accepted: 2026-06-25
Auditor: KPMG LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.839 Blood Diseases and Resources Research $1.07M Yes 0
93.351 Research Infrastructure Programs $1.04M Yes 0
93.376 Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients $347,297 Yes 0
81.049 Office of Science Financial Assistance Program $320,357 Yes 0
93.350 National Center for Advancing Translational Sciences $302,919 Yes 0
93.213 Research and Training in Complementary and Alternative Medicine $281,100 Yes 0
93.172 Human Genome Research $270,782 Yes 0
93.855 Allergy and Infectious Diseases Research $261,212 Yes 0
12.750 Uniformed Services University Medical Research Projects $251,646 Yes 0
93.393 Cancer Cause and Prevention Research $188,667 Yes 0
12.420 Military Medical Research and Development $177,996 Yes 0
93.837 Cardiovascular Diseases Research $149,601 Yes 0
12.RD Contract $143,792 Yes 0
93.396 Cancer Biology Research $142,174 Yes 0
93.353 21st Century Cures Act - Beau Biden Cancer Moonshot $128,725 Yes 0
47.074 Biological Sciences $124,278 Yes 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $117,150 Yes 0
93.307 Minority Health and Health Disparities Research $104,131 Yes 0
93.RD Contract $103,167 Yes 0
93.395 Cancer Treatment Research $102,435 Yes 0
93.384 Advanced Research Projects Agency for Health (ARPA-H) $92,665 Yes 0
93.242 Mental Health Research Grants $91,657 Yes 0
93.233 National Center on Sleep Disorders Research $86,086 Yes 0
93.399 Cancer Control $79,753 Yes 0
93.865 Child Health and Human Development Extramural Research $76,582 Yes 0
47.049 Mathematical and Physical Sciences $73,801 Yes 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $67,898 Yes 0
93.304 Racial and Ethnic Approaches to Community Health $58,546 Yes 0
93.103 Food and Drug Administration - Research $52,267 Yes 0
93.361 Nursing Research $48,246 Yes 0
47.084 Technology, Innovation, and Partnerships $44,034 Yes 0
93.310 Trans-NIH Research Support $41,676 Yes 0
93.838 Lung Diseases Research $39,229 Yes 0
93.262 Occupational Safety and Health Program $39,036 Yes 0
93.279 Drug Use and Addiction Research Programs $33,189 Yes 0
93.397 Cancer Centers Support Grants $30,628 Yes 0
64.105 Pension to Veterans Surviving Spouses, and Children $27,024 Yes 0
93.866 Aging Research $23,326 Yes 0
93.846 Arthritis, Musculoskeletal and Skin Diseases Research $17,510 Yes 0
93.398 Cancer Research Manpower $16,625 Yes 0
93.879 Medical Library Assistance $13,673 Yes 0
93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health $12,007 Yes 0
93.394 Cancer Detection and Diagnosis Research $10,049 Yes 0
93.121 Oral Diseases and Disorders Research $-71 Yes 0
93.859 Biomedical Research and Research Training $-83 Yes 0
93.867 Vision Research $-8,128 Yes 0

Contacts

Name Title Type
DPMGH9MG1X67 Katrina Kyle Auditee
6175827818 Jayme Silva Auditor
No contacts on file

Notes to SEFA

The accompanying Supplementary Schedule of Expenditures of Federal Awards (Schedule) presents the activity of all federal awards of Dana-Farber Cancer Institute, Inc. and Subsidiaries (the Institute). All federal awards received directly from federal agencies, as well as federal awards passed through to the Institute from other agencies, are included on the Schedule. The Schedule also denotes Assistance Listing Numbers for each award and awards passed through from the Institute to other nonfederal subrecipient organizations.
The Schedule is prepared on the accrual basis of accounting. Since the Schedule presents only a selected portion of the operations of the Institute, it is not intended to and does not present the consolidated financial position or changes in net assets of the Institute.
Indirect costs are charged to federal grants and contracts at federally approved predetermined rates. Indirect costs recovered are included in reported federal expenditures. The Institute has elected to not use the de minimis indirect cost rate allowed under the Uniform Guidance